Alpharetroviral vectors for the gene therapy of X-CGD

被引：0
|
作者：
Kaufmann, K. B. [1 ]
Suerth, J. D. [2 ]
Brendel, C. [1 ]
Schambach, A. [2 ]
Baum, C. [2 ]
Grez, M. [1 ]
机构：
[1] Georg Speyer Haus, D-60596 Frankfurt, Germany
[2] Hannover Med Sch, D-30625 Hannover, Germany
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A101 / A102
页数：2
相关论文
共 50 条
  • [11] Correction of the X-CGD phenotype by a self-inactivating alpharetroviral vector in human and murine models
    Kaufmann, Kerstin B.
    Brendel, Christian
    Suerth, Julia D.
    Chen-Wichmann, Linping
    Schwaeble, Joachim
    Kunkel, Hana
    Schambach, Axel
    Baum, Christopher
    Grez, Manuel
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A32 - A32
  • [12] PRECLINICAL STUDIES TO IMPROVE THE EFFICACY OF STEM CELL GENE THERAPY FOR X-CGD
    Takeuchi, Yasuo
    Otsu, Makoto
    Onodera, Masafumi
    Kume, Akihiro
    Nakauchi, Hiromitsu
    [J]. JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1064 - 1064
  • [13] Regulated lentiviral vector gene transfer for X-CGD
    Capo, Valentina
    Farinelli, Giada
    Gentner, Bernhard
    Di Matteo, Gigliola
    Di Cesare, Silvia
    Scaramuzza, Samantha
    Sergi, Lucia Sergi
    Grez, Manuel
    Trono, Didier
    Finocchi, Andrea
    Rossi, Paolo
    Naldini, Luigi
    Chiriaco, Maria
    Aiuti, Alessandro
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A52 - A52
  • [14] Lentiviral vectors for gene-therapy of X-CGD: specific and high expression of gp91phox restricted to granulocytes
    Brendel, Christian
    Stein, Stefan
    Antoniou, Michael
    Grez, Manuel
    [J]. HUMAN GENE THERAPY, 2008, 19 (10) : 1132 - 1132
  • [15] REGULATED LENTIVIRAL VECTOR GENE TRANSFER FOR X-CGD
    Chiriaco, M.
    Farinelli, G.
    Capo, V.
    Di Matteo, G.
    Di Cesare, S.
    Scaramuzza, S.
    Sergi, L. Sergi
    Grez, M.
    Trono, D.
    Finocchi, A.
    Rossi, P.
    Naldini, L.
    Gentner, B.
    Aiuti, A.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 126 - 127
  • [16] THE PITFALLS OF SEQUENCING - REVISED SEQUENCE OF THE X-CGD GENE
    ORKIN, SH
    [J]. TRENDS IN GENETICS, 1987, 3 (08) : 207 - 207
  • [17] Phase I/II gene therapy study for X-CGD: Results, lessons and perspectives
    Grez, Manuel
    Ott, Marion G.
    Stein, Stefan
    Schultze-Strasser, Stephan
    Preiss, Carolin
    Kramer, Rolf
    Schmidt, Manfred
    Kunkel, Hana
    von Kalle, Christof
    Thrasher, Adrian
    Hoelzer, Dieter
    Seger, Reinhard
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (02) : 268 - 269
  • [18] Development of experimental animal model to improve the efficacy of human gene therapy for X-CGD
    Takeuchi, Y.
    Amirhosseini, M.
    Franklin, L.
    Takeuchi, E.
    Nakauchi, H.
    Otsu, M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S182 - S182
  • [19] Development of a new strategy for X-CGD gene therapy using a miRNA regulated lentiviral vector
    Farinelli, G.
    Chiriaco, M.
    Gentner, B.
    Di Matteo, G.
    Capo, V.
    Di Cesare, S.
    Scaramuzza, S.
    Sergi, L. Sergi
    Grez, M.
    Isgro, A.
    Finocchi, A.
    Rossi, P.
    Naldini, L.
    Aiuti, A.
    [J]. HUMAN GENE THERAPY, 2011, 22 (10) : A28 - A28
  • [20] Hematopoietic stem cell gene therapy using a selective amplifier gene in a murine X-CGD model.
    Hara, T
    Kume, A
    Hanazono, Y
    Mizukami, HI
    Okada, T
    Tsurumi, H
    Moriwaki, H
    Hasegawa, M
    Ozawa, K
    [J]. BLOOD, 2002, 100 (11) : 117A - 117A
12345